Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 3/20 | 0.56 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA12 | O43570 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2404045 | 0.98 | F2 (0.54) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL10609196 | 0.95 | F2 (0.51) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL18087461 | 0.85 | F2 (0.40) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL10823807 | 0.84 | CA1 (0.43) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL2404043 | 0.84 | ALDH1A1 (0.39) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL19887234 | 0.82 | BCL2L1 (0.41) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL11668407 | 0.81 | LCK (0.47) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL9241270 | 0.80 | F2 (0.60) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL9645847 | 0.79 | LMNA (0.46) | F2PRSS1PRSS2PRSS3CA2 | |
| Ammonia Solution, Strong SCHEMBL11668387 | 0.78 | F2 (0.59) | F2PRSS1PRSS2PRSS3CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | claimed |
| US-20250067749-A1 | A Diazo Compound And A Preparation Method And A Use Thereof | PEKING UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| CN-119287709-A | High-strength compression-resistant corrugated carton and preparation process thereof | 常州市正文印刷有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-20240384269-A1 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSIOCHEMICAL CHARACTERISTICS | Sixfold Bioscience Ltd. (GB) | 2024-11-21 | — | — | US | claimed |
| EP-4323517-A2 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS | Sixfold Bioscience Ltd. (GB) | 2024-02-21 | — | — | EP | claimed |
| CN-117003696-A | Diazonium compound and preparation method and application thereof | 北京大学 | 2023-11-07 | — | — | CN | claimed |
| WO-2023208233-A1 | DIAZO COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 北京大学 | 2023-11-02 | — | — | WO | claimed |
| EP-4143316-A2 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY | Sixfold Bioscience Ltd. (GB) | 2023-03-08 | — | — | EP | claimed |
| US-20220370635-A1 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY | SIXFOLD BIOSCIENCE LTD (GB) | 2022-11-24 | — | — | US | claimed |
| WO-2022219409-A2 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS | Sixfold Bioscience Ltd. (GB) | 2022-10-20 | — | — | WO | claimed |
| WO-1988000197-A1 | BENZOPYRAN AND BENZOTHIOPYRAN DERIVATIVES AND COMPOSITIONS CONTAINING THEM | ALKALOIDA VEGYE^´SZETI GYA^´R (HU) | 1988-01-14 | — | — | WO | claimed |
| US-4616084-A | Process for the preparation of 7-acylamino-3-hydroxy-cephem-4-carboxylic acids and 7-acylamino-3-hydroxy-1-dethia-1-oxacephem-4-carboxylic acids | BAYER AKTIENGESELLSCHAFT (DE) | 1986-10-07 | — | — | US | claimed |
| US-4596582-A | Improved adhesion to polymer matrix | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-06-24 | — | — | US | claimed |
| EP-0179551-A2 | Concrete reinforcement | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-30 | — | — | EP | claimed |
| US-4515636-A | BENZENESULFONYL AZIDE COATED FIBERS TO IMPROVE ADHESION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-05-07 | — | — | US | claimed |
| EP-0135282-A1 | Aramid fiber coated with sulfonyl azide | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-03-27 | — | — | EP | claimed |
| EP-0133670-A2 | Process for the preparation of 7-acylamino-3-hydroxy-cephem-4-carboxylic acids and 7-acylamino-3-hydroxy-1-dethia-1-oxacephem-4-carboxylic acids | BAYER AG (DE) | 1985-03-06 | — | — | EP | claimed |
| US-4383946-A | Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals | MERCK & CO., INC. (US) | 1983-05-17 | — | — | US | claimed |
| US-4103616-A | Elastomers and improved waterless lithographic printing masters | XEROX CORPORATION (US) | 1978-08-01 | — | — | US | claimed |
| US-4100135-A | Novel elastomers and improved waterless lithographic printing masters | XEROX CORPORATION (US) | 1978-07-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220370635-A1 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY | NCL, NSUN3, POLN | F2 4522/4885PRSS1 4247/4885PRSS2 4589/4885 |
| US-20250067749-A1 | A Diazo Compound And A Preparation Method And A Use Thereof | DAO, DDC, DDO | F2 612/4885PRSS1 4293/4885PRSS2 3219/4885 |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | NCL, NSUN3, POLN | F2 4522/4885PRSS1 4247/4885PRSS2 4589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.